CNS Pharmaceuticals (CNSP) Reports Q4 Loss of $0.17/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts CNSP Hot Sheet
Join SI Premium – FREE
CNS Pharmaceuticals (NASDAQ: CNSP) reported Q4 EPS of ($0.17), versus ($0.63) reported last year.
For earnings history and earnings-related data on CNS Pharmaceuticals (CNSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Why Beijing could block the SpaceX-Tesla merger
- Arbor Realty Trust (ABR) Misses Q3 EPS by 8c
- AbbVie beats estimates but stock dips
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
